Skip to Content
BiomoleculesBiomolecules
  • Article
  • Open Access

3 July 2023

12 Pages

Chemically-Modified Sepharose 6B Beads for Collection of Circulating Tumor Cells

,
,
,
and
1
The National and Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, Hunan Normal University, Changsha 410081, China
2
East China Institute of Digital Medical Engineering, Shangrao 334000, China
3
Department of Bioengineering, University of California-Berkeley, Berkeley, CA 94720, USA
*
Authors to whom correspondence should be addressed.

Abstract

The isolation and quantitative characterization of circulating tumor cells (CTCs) are of great importance in cancer diagnosis and prognosis. However, isolating and detecting CTCs in whole blood presents a significant challenge due to the low numbers of CTCs (often ranging from one to five) in samples containing billions of erythrocytes. Recently, point-of-care devices that use antibody trapping coupled with remote immunofluorescence analyses have been described to identify the number and type of CTCs in blood. In this study, we propose a novel method for trapping and quantifying CTCs using Sepharose 6B beads of 45–160 μm size that are engineered with capture antibodies. Specifically, we employed CD44 antibody conjugates (bearing a maleimide group) that are specific to the CTCs of breast cancer to thiol-Sepharose beads 6B. These beads, when mixed with MDAMB231 and Jurkat cells and filtered through a 40 μm filter, can capture ~80% of MDAMB231 cells. Furthermore, the antibody-modified Sepharose 6B can be stored at four degrees Celsius for a period exceeding six months.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.